VTR Biotech successfully participated in VIV Asia 2025, one of the premier international events for the animal feed and ...

AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal ...

(MENAFN- IANS) New Delhi, March 31 (IANS) Biotechnology remains a priority sector in India, said Union Minister of State (Independent Charge) for Science and Technology Jitendra Singh on Monday.

TAIPEI, Taiwan, March 13, 2025 (GLOBE NEWSWIRE) -- New-generation Contract Development and Manufacturing Organization (CDMO) Amaran Biotech has been awarded the prestigious “Bioprocessing ...

Apollomics has sold the rights to its lead c-MET inhibitor in Asia, excluding Greater China, to Taiwan’s LaunXP Biomedical for $10 million upfront. The drug, called vebreltinib, has already been ...

AstraZeneca has tapped Korea's Alteogen to develop subcutaneous cancer drugs. Taiho Pharmaceutical is paying $400 million to ...